NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,386,000 | -5.2% | 285,716 | +22.1% | 0.16% | -10.9% |
| Q2 2018 | $1,462,000 | -24.6% | 233,972 | +0.1% | 0.18% | -28.2% |
| Q1 2018 | $1,940,000 | -22.9% | 233,762 | -5.2% | 0.26% | -23.2% |
| Q4 2017 | $2,515,000 | +15.4% | 246,523 | +3.5% | 0.33% | +12.2% |
| Q3 2017 | $2,179,000 | +55.6% | 238,152 | +24.2% | 0.30% | +48.0% |
| Q2 2017 | $1,400,000 | – | 191,729 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 693,582 | $4,057,000 | 2.30% |
| DAFNA Capital Management LLC | 38,873 | $227,000 | 0.20% |
| FALCON POINT CAPITAL, LLC | 85,588 | $501,000 | 0.07% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,341,000 | 0.06% |
| Cormorant Asset Management, LP | 50,613 | $296,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 14,587 | $85,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $468,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 296,175 | $1,733,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,315,500 | $7,696,000 | 0.00% |
| COLUMBUS CIRCLE INVESTORS | 42,304 | $247,000 | 0.00% |